Related references
Note: Only part of the references are listed.Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria
Zahinoor Ismail et al.
INTERNATIONAL PSYCHOGERIATRICS (2018)
Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease
Nicole Cortes et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia
Jules Mathys et al.
EXPERIMENTAL GERONTOLOGY (2017)
Trajectories of depressive symptoms and their relationship to the progression of dementia
Maria Lage Barca et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study
Babette L. R. Reijs et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre- Dementia Populations
Zahinoor Ismail et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease
Claudio Liguori et al.
JOURNAL OF NEUROLOGY (2017)
Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology
D. Tautvydaite et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process
Audrey Gabelle et al.
NEUROBIOLOGY OF AGING (2017)
Biomarkers of aggression in dementia
Kristina Gotovac et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Neuropsychiatric Symptoms as Predictors of Progression to Severe Alzheimer's Dementia and Death: The Cache County Dementia Progression Study
Matthew E. Peters et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI
Steffen Wolfsgruber et al.
NEUROLOGY (2015)
Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment
E. Auning et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer's disease
Hung-Chou Kuo et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2015)
Cerebrospinal Fluid α-Synuclein and Lewy Body-Like Symptoms in Normal Controls, Mild Cognitive Impairment, and Alzheimer's Disease
R. Scott Mackin et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Regional Cortical Thinning Predicts Worsening Apathy and Hallucinations Across the Alzheimer Disease Spectrum
Nancy J. Donovan et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy
Yves A. Dauvilliers et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
Claudio Liguori et al.
JAMA NEUROLOGY (2014)
Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
Victor Bloniecki et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2014)
Elevated CSF Tau is Associated With Psychosis in Alzheimer's Disease
Jeremy Koppel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment
I. H. G. B. Ramakers et al.
PSYCHOLOGICAL MEDICINE (2013)
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease
Michael Ewers et al.
NEUROBIOLOGY OF AGING (2012)
Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease
Milica Gregoric Kramberger et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2012)
Impact of neuropsychiatric symptoms on caregiver burden in patients with Alzheimer's disease
Corinne Eleanor Fischer et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2012)
Neuropsychiatric symptoms in Alzheimer’s disease
Constantine G. Lyketsos et al.
Alzheimers & Dementia (2011)
Alzheimer disease biomarkers are associated with body mass index
E. D. Vidoni et al.
NEUROLOGY (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease
Ragnhild Skogseth et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Martin Steinberg et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
The contribution of neuropsychiatric symptoms to the cost of dementia care
Nathan Herrmann et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression
Witte J. G. Hoogendijk et al.
NEUROBIOLOGY OF AGING (2006)
Neuropsychological and behavioural correlates of CSF biomarkers in dementia
S Engelborghs et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
The role of social groups in the persistence of learned fear
A Olsson et al.
SCIENCE (2005)
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment - Results from the Cardiovascular Health Study
CG Lyketsos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
